HC Wainwright & Co. Reiterates Buy on Dynavax Technologies, Maintains $29 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Edward White has reiterated a Buy rating on Dynavax Technologies (NASDAQ:DVAX) and maintained a $29 price target.
June 28, 2024 | 10:28 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Edward White has reiterated a Buy rating on Dynavax Technologies and maintained a $29 price target.
The reiteration of a Buy rating and the maintenance of a $29 price target by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100